# Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis

> **NCT06925490** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Cairo University** · enrollment: 50 (estimated)

## Conditions studied

- Irreversible Pulpitis
- Primary Teeth
- Pulp Disease, Dental

## Interventions

- **DRUG:** Metapex
- **DRUG:** 3Mixtatin

## Key facts

- **NCT ID:** NCT06925490
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2025-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06925490

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06925490, "Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06925490. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*